Thus, considering the results obtained, it can be hypothesized that in the case of CTSB application in anti-amyloid therapy, the enzyme will exhibit a universal dual mechanism of action on fibrils regardless of the pathology and type of amyloids causing it. This evidence concerns the gene CTSB and amyloidosis.